End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.74 CNY | -3.94% | -1.17% | -44.81% |
Apr. 26 | Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | China Stocks Fall Ahead of March Economic Data Release | MT |
Sales 2024 * | 130M 17.99M | Sales 2025 * | 487M 67.41M | Capitalization | 2.85B 394M |
---|---|---|---|---|---|
Net income 2024 * | -472M -65.34M | Net income 2025 * | -124M -17.16M | EV / Sales 2024 * | 21.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.84 x |
P/E ratio 2024 * |
-6.03
x | P/E ratio 2025 * |
-23.1
x | Employees | 181 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
1 day | -3.94% | ||
1 week | -1.17% | ||
Current month | -1.17% | ||
1 month | -1.34% | ||
3 months | -17.98% | ||
6 months | -36.79% | ||
Current year | -44.81% |
Managers | Title | Age | Since |
---|---|---|---|
Xing Hai Li
FOU | Founder | 61 | 13-02-04 |
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 13-02-04 |
Ze Yan Shi
DFI | Director of Finance/CFO | 43 | 21-11-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 13-02-04 |
Xing Hai Li
FOU | Founder | 61 | 13-02-04 |
Yuan Lun Chen
BRD | Director/Board Member | 54 | 20-09-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 28.74 | -3.94% | 950,518 |
24-05-09 | 29.92 | -0.27% | 631,829 |
24-05-08 | 30 | -1.48% | 674,353 |
24-05-07 | 30.45 | +0.26% | 879,013 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.81% | 394M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 688302 Stock